Pair Name | Ursodiol, Bortezomib | ||
Phytochemical Name | Ursodiol (PubChem CID: 31401 ) | ||
Anticancer drug Name | Bortezomib (PubChem CID: 387447 ) | ||
Structure of Phytochemical |
Download
2D
MOL
3D
MOL
|
||
Structure of Anticancer Drug |
Download
2D
MOL
3D
MOL
|
Pair Name | Ursodiol, Bortezomib | |||
Disease Info | [ICD-11: 2A00] | Glioblastoma multiforme | Investigative | |
Biological Phenomena | Induction-->Endoplasmic reticulum stress | |||
Gene Regulation | Up-regulation | Expression | ATF4 | hsa468 |
Up-regulation | Expression | DDIT3 | hsa1649 | |
Up-regulation | Expression | EIF2AK3 | hsa9451 | |
Up-regulation | Expression | ROS1 | hsa6098 | |
In Vitro Model | A-172 | Glioblastoma | Homo sapiens (Human) | CVCL_0131 |
LN-229 | Glioblastoma | Homo sapiens (Human) | CVCL_0393 | |
U-87MG ATCC | Glioblastoma | Homo sapiens (Human) | CVCL_0022 | |
U-251MG | Astrocytoma | Homo sapiens (Human) | CVCL_0021 | |
Result | Ursodeoxycholic Acid Inhibits Glioblastoma Progression via Endoplasmic Reticulum Stress Related Apoptosis and Synergizes with the Proteasome Inhibitor Bortezomib |
No. | Title | Href |
---|---|---|
1 | Ursodeoxycholic Acid Inhibits Glioblastoma Progression via Endoplasmic Reticulum Stress Related Apoptosis and Synergizes with the Proteasome Inhibitor Bortezomib. ACS Chem Neurosci. 2020 May 6;11(9):1337-1346. doi: 10.1021/acschemneuro.0c00095. | Click |